Jordan J Feld

Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study

G. Dore, M. van der Valk, S. Barbieri, 2023, Journal of the International AIDS Society.

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.

R. Peeling, Rakesh Aggarwal, S. Taylor-Robinson, 2019, The lancet. Gastroenterology & hepatology.

Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials.

A. Mangia, G. Dore, S. Zeuzem, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

M. Hellard, J. Grebely, P. Bruggmann, 2015, The International journal on drug policy.

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use

M. Hellard, G. Dore, P. Bruggmann, 2018 .

Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study

M. Vachon, M. Swain, R. Bailey, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free era.

D. Tyrrell, M. Houghton, Jennifer F. Raven, 2014, Canadian journal of gastroenterology & hepatology.

Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.

T. Liang, J. Feld, M. Fried, 2007, Gastroenterology.

Joint statement in support of hepatitis C human challenge studies.

Daniel M. Haybron, S. Pinker, G. Lauer, 2023, The lancet. Gastroenterology & hepatology.